ENSEM Therapeutics is a biotechnology company focusing on high value and difficult-to-drug oncology targets
ENSEM Therapeutics is a pioneering drug discovery and development company that leverages its unique Kinetic EnsembleTM platform to develop innovative small-molecule precision medicines for oncology, with potential expansion into genetic disorders and other disease areas.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 6, 2022 | Series A | $67M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
|
— | Series A |
![]() |
— | Series A |